Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 8/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13309598 | 0.92 | THRB (0.64) | THRBTSHRL3MBTL1ACHEGLA | |
| SCHEMBL8928140 | 0.90 | TSHR (0.54) | THRBTSHRACHE | |
| SCHEMBL6255228 | 0.89 | THRB (0.45) | THRBTSHRL3MBTL1ACHEALDH1A1 | |
| SCHEMBL2403793 | 0.89 | THRB (0.53) | THRBTSHRL3MBTL1ACHEALDH1A1 | |
| SCHEMBL13872030 | 0.89 | THRB (0.53) | THRBTSHRL3MBTL1ACHEALDH1A1 | |
| SCHEMBL15128211 | 0.89 | THRB (0.47) | THRBTSHRL3MBTL1ACHEMGAM | |
| SCHEMBL17225745 | 0.88 | TSHR (0.57) | THRBTSHRACHE | |
| SCHEMBL6253394 | 0.88 | TSHR (0.51) | THRBTSHRACHE | |
| SCHEMBL6256032 | 0.87 | THRB (0.72) | THRBTSHRL3MBTL1ACHEALDH1A1 | |
| SCHEMBL10331942 | 0.87 | ACHE (0.54) | THRBTSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005055959-A2 | BULKY MONOMERS LEADING TO RESINS EXHIBITING LOW POLYMERIZATION SHRINKAGE | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-06-23 | — | — | WO | claimed |
| US-20050124721-A1 | Bulky monomers leading to resins exhibiting low polymerization shrinkage | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-06-09 | — | — | US | claimed |
| EP-4581069-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2025-07-09 | — | — | EP | disclosed |
| US-20250197690-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2025-06-19 | — | — | US | disclosed |
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12037463-B2 | Antimicrobial ophthalmic devices comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2024-07-16 | — | — | US | disclosed |
| WO-2024046703-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2024-03-07 | — | — | WO | disclosed |
| US-20240066790-A1 | Process and apparatus for locally polymerizing a starting material by dual color photopolymerization and method for volumetric printing of a shaped body | XOLO GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| EP-4326789-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2024-02-28 | — | — | EP | disclosed |
| US-20240052219-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-02-15 | — | — | US | disclosed |
| WO-2005055959-A2 | BULKY MONOMERS LEADING TO RESINS EXHIBITING LOW POLYMERIZATION SHRINKAGE | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-06-23 | — | — | WO | disclosed |
| WO-2005055961-A1 | DENTAL COMPOSITIONS CONTAINING CORE-SHELL POLYMERS WITH LOW MODULUS CORES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-06-23 | — | — | WO | disclosed |
| US-20050124721-A1 | Bulky monomers leading to resins exhibiting low polymerization shrinkage | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-06-09 | — | — | US | disclosed |
| US-20050124762-A1 | Dental compositions containing core-shell polymers with low modulus cores | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-06-09 | — | — | US | disclosed |
| US-5840806-A | COMPOSITION COMPRISING RESIN FORMED BY CONDENSATION OF POLYSILOXANE WITH POLYMER HAVING HYDROLYZABLE SILYL GROUP AND ADDITIONAL FUNCTIONAL GROUP, COMPOUND CAPABLE OF REACTING WITH SAID GROUP | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-11-24 | — | — | US | disclosed |
| EP-0495269-B1 | Thermosetting reactive resin mixture, moulded article and coating made therefrom | DAINIPPON INK & CHEMICALS (JP) | 1997-03-05 | — | — | EP | disclosed |
| US-5292833-A | Polyepoxide compound, carbamate compound and catalyst | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1994-03-08 | — | — | US | disclosed |
| WO-1992012192-A2 | THERMOSETTING REACTIVE RESIN MIXTURE, MOULDED ARTICLE AND COATING MADE THEREFROM | DAINIPPON INK & CHEMICALS, INC. (JP) | 1992-07-23 | — | — | WO | disclosed |
| EP-0495269-A2 | Thermosetting reactive resin mixture, moulded article and coating made therefrom | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1992-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124721-A1 | Bulky monomers leading to resins exhibiting low polymerization shrinkage | REV1, TERB1, RAD51 | THRB 4766/4885TSHR 4811/4885L3MBTL1 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.